vs
Akso Health Group（AHG）与拼多多（PDD）财务数据对比。点击上方公司名可切换其他公司
拼多多的季度营收约是Akso Health Group的2172.7倍（$15.2B vs $7.0M）。拼多多净利率更高（27.1% vs -18.6%，领先45.7%）
阿克索健康集团是一家跨国医疗健康企业，专注于仿制药、非处方健康产品及医疗器械的研发、生产与分销，核心市场覆盖中国、东南亚及北美地区，业务范畴包含药品制造、医疗供应链及社区医疗服务板块。
PDD控股是总部位于爱尔兰的跨国企业，旗下拥有中国头部线上零售平台拼多多和跨境电商平台Temu。拼多多主打农业供应链数字化升级，助力农产品直接对接广大消费者需求。
AHG vs PDD — 直观对比
营收规模更大
PDD
是对方的2172.7倍
$7.0M
净利率更高
PDD
高出45.7%
-18.6%
损益表 — Q2 2026 vs Q3 2025
| 指标 | | |
|---|---|---|
| 营收 | $7.0M | $15.2B |
| 净利润 | $-1.3M | $4.1B |
| 毛利率 | 8.9% | 56.7% |
| 营业利润率 | -20.5% | 23.1% |
| 净利率 | -18.6% | 27.1% |
| 营收同比 | — | — |
| 净利润同比 | — | — |
| 每股收益（稀释后） | — | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AHGPDD
| Q3 25 | $7.0M | $15.2B | ||
| Q2 25 | — | $14.5B | ||
| Q3 24 | — | $14.2B | ||
| Q1 24 | — | $12.0B | ||
| Q3 23 | — | $9.4B | ||
| Q2 23 | — | $7.2B | ||
| Q4 22 | — | $5.8B | ||
| Q3 22 | — | $5.0B |
净利润AHGPDD
| Q3 25 | $-1.3M | $4.1B | ||
| Q2 25 | — | $4.3B | ||
| Q3 24 | — | $3.6B | ||
| Q1 24 | — | $3.9B | ||
| Q3 23 | — | $2.1B | ||
| Q2 23 | — | $1.8B | ||
| Q4 22 | — | $1.4B | ||
| Q3 22 | — | $1.5B |
毛利率AHGPDD
| Q3 25 | 8.9% | 56.7% | ||
| Q2 25 | — | 55.9% | ||
| Q3 24 | — | 60.0% | ||
| Q1 24 | — | 62.3% | ||
| Q3 23 | — | 61.0% | ||
| Q2 23 | — | 64.3% | ||
| Q4 22 | — | 77.6% | ||
| Q3 22 | — | 79.1% |
营业利润率AHGPDD
| Q3 25 | -20.5% | 23.1% | ||
| Q2 25 | — | 24.8% | ||
| Q3 24 | — | 24.5% | ||
| Q1 24 | — | 29.9% | ||
| Q3 23 | — | 24.2% | ||
| Q2 23 | — | 24.3% | ||
| Q4 22 | — | 22.9% | ||
| Q3 22 | — | 29.4% |
净利率AHGPDD
| Q3 25 | -18.6% | 27.1% | ||
| Q2 25 | — | 29.6% | ||
| Q3 24 | — | 25.1% | ||
| Q1 24 | — | 32.3% | ||
| Q3 23 | — | 22.6% | ||
| Q2 23 | — | 25.1% | ||
| Q4 22 | — | 23.7% | ||
| Q3 22 | — | 29.8% |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $11.1M | $13.0B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $198.3M | $55.0B |
| 总资产 | $212.0M | $86.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AHGPDD
| Q3 25 | $11.1M | $13.0B | ||
| Q2 25 | — | $8.8B | ||
| Q3 24 | — | $9.3B | ||
| Q1 24 | — | $7.7B | ||
| Q3 23 | — | $7.5B | ||
| Q2 23 | — | $4.3B | ||
| Q4 22 | — | $21.7B | ||
| Q3 22 | — | $3.6B |
股东权益AHGPDD
| Q3 25 | $198.3M | $55.0B | ||
| Q2 25 | — | $50.5B | ||
| Q3 24 | — | $39.7B | ||
| Q1 24 | — | $30.3B | ||
| Q3 23 | — | $22.2B | ||
| Q2 23 | — | $20.0B | ||
| Q4 22 | — | $17.1B | ||
| Q3 22 | — | $15.1B |
总资产AHGPDD
| Q3 25 | $212.0M | $86.2B | ||
| Q2 25 | — | $79.2B | ||
| Q3 24 | — | $66.5B | ||
| Q1 24 | — | $52.3B | ||
| Q3 23 | — | $43.1B | ||
| Q2 23 | — | $37.8B | ||
| Q4 22 | — | $34.4B | ||
| Q3 22 | — | $29.4B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.2M | $6.4B |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 1.56× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流AHGPDD
| Q3 25 | $1.2M | $6.4B | ||
| Q2 25 | — | $3.0B | ||
| Q3 24 | — | $3.9B | ||
| Q1 24 | — | $2.9B | ||
| Q3 23 | — | $4.5B | ||
| Q2 23 | — | $3.2B | ||
| Q4 22 | — | $7.0B | ||
| Q3 22 | — | $1.6B |
现金转化率AHGPDD
| Q3 25 | — | 1.56× | ||
| Q2 25 | — | 0.70× | ||
| Q3 24 | — | 1.10× | ||
| Q1 24 | — | 0.75× | ||
| Q3 23 | — | 2.09× | ||
| Q2 23 | — | 1.78× | ||
| Q4 22 | — | 5.13× | ||
| Q3 22 | — | 1.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
